Effects of Shenkang Pills on Early-Stage Diabetic Nephropathy in db/db Mice via Inhibiting AURKB/RacGAP1/RhoA Signaling Pathway

Diabetic nephropathy (DN) is the leading cause of end-stage renal disease, so there is an urgent need to suppress its development at early stage. Shenkang pills (SKP) are a hospital prescription selected and optimized from effective traditional Chinese medicinal formulas for clinical treatment of DN...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Fujing, Fan, Jia’er, Pei, Tingting, He, Zhuo’en, Zhang, Jiaxing, Ju, Liliang, Han, Zhongxiao, Wang, Mingqing, Xiao, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873791/
https://www.ncbi.nlm.nih.gov/pubmed/35222021
http://dx.doi.org/10.3389/fphar.2022.781806

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873791/
https://www.ncbi.nlm.nih.gov/pubmed/35222021
http://dx.doi.org/10.3389/fphar.2022.781806

Ejemplares similares